News
Tirzepatide promoted greater weight loss in individuals with obesity than semaglutide in a clinical trial that compared the ...
The boss of the drugs giant behind Ozempic has quit after falling behind in the global race to develop weight-loss medication ...
10m
Yen on MSNOzempic-maker Novo Nordisk says CEO to step downDanish drugmaker Novo Nordisk, known for its blockbuster diabetes and weight-loss treatments Ozempic and Wegovy, said Friday ...
Novo Nordisk said Jørgensen will remain in his role temporarily to ensure a “smooth transition” while a search for his ...
It’s the end of an era at Novo Nordisk as longtime CEO Lars Fruergaard Jørgensen—who recently shepherded the company through ...
Eli Lilly and Company (NYSE:LLY) is a leading medicine company which discovers, develops, manufactures, and markets products ...
13h
Health and Me on MSNScented Candles Are Harming Your Lungs—Here's HowScented candles have taken the market by storm. Known to be therapeutic, these candles are quickly making their way into our ...
Eli Lilly and Company ( NYSE: LLY) BofA Securities 2025 Health Care Conference Call May 15, 2025 11:40 AM ET Lucas Montarce - CFO Mike Czapar - SVP, IR ...
People look at a Can-Am Pulse electric motorcycle during the EV & Charging Expo 2025 in Toronto, Canada, on May 15, 2025.
Hong Kong's stock market ended lower Friday with the benchmark Hang Seng Index down 0.46 percent to close at 23,345.05 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results